What are the diagnostic criteria for fibromyalgia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 31, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Fibromyalgia Diagnostic Criteria

Fibromyalgia is diagnosed clinically using the American College of Rheumatology (ACR) criteria, which focus on chronic widespread pain lasting at least 3 months combined with a Widespread Pain Index (WPI) ≥7 and Symptom Severity (SS) scale ≥5, eliminating the outdated requirement for tender point examination. 1, 2

Modern ACR Diagnostic Criteria (2010-Present)

The current diagnostic approach requires:

  • Widespread Pain Index (WPI) ≥7 AND Symptom Severity (SS) scale ≥5 as the primary diagnostic threshold 2, 3
  • Chronic widespread pain present for at least 3 months in all four body quadrants (left side, right side, above waist, below waist) plus axial skeletal pain 1, 2
  • The SS scale incorporates categorical ratings for cognitive symptoms, unrefreshed sleep, fatigue, and number of somatic symptoms 2

The 1990 tender point criteria (requiring 11 of 18 tender points with 4 kg/cm² pressure) are no longer recommended, as the focus on tender points was not justified and has been replaced by the more comprehensive symptom-based approach 2, 4

Core Clinical Features Required

  • Pain characteristics: Chronic widespread pain with hyperalgesia and allodynia present in all four body quadrants for minimum 3 months 1
  • Fatigue: Disproportionate to activity level 1, 3
  • Sleep disturbances: Non-restorative sleep 1, 3
  • Cognitive dysfunction: Often described as "fibro fog" 1, 3

Associated Symptoms That Strengthen Diagnosis

  • Mood disturbances including anxiety and depression 1
  • Stiffness 5
  • Multiple somatic symptoms that overlap with other central sensitivity syndromes 6, 5

Screening Tools

  • Fibromyalgia Rapid Screening Tool is recommended for initial screening in patients presenting with diffuse chronic pain 3
  • The Fibromyalgia Impact Questionnaire (FIQ) measures functional impairment and impact on daily activities, though it is used for assessment rather than diagnosis 1

Essential Laboratory Exclusion Testing

Basic laboratory screening is required to exclude mimicking conditions, not to diagnose fibromyalgia:

  • Erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP) to exclude inflammatory diseases 1
  • Thyroid function tests to exclude endocrine disorders 1
  • Creatine kinase to rule out myopathies 1
  • Vitamin D levels 1

There are no laboratory abnormalities that confirm fibromyalgia—it remains a clinical diagnosis 4

Critical Diagnostic Pitfalls to Avoid

  • Do not treat fibromyalgia as a diagnosis of exclusion—it is a positive clinical diagnosis based on specific criteria 4
  • Do not perform tender point examination as the primary diagnostic method, as this outdated approach has been replaced by the WPI and SS scale 2
  • Do not order excessive testing—establishing the diagnosis early can reassure patients and decrease unnecessary healthcare utilization, which averages 3.7 consultations with different physicians over 2+ years when diagnosis is delayed 1, 3
  • Do not assume unilateral or focal symptoms rule out fibromyalgia, but investigate these thoroughly as they may represent comorbid conditions requiring separate treatment 7

Differential Diagnoses to Consider

  • Chronic fatigue syndrome may coexist or present similarly 1, 6
  • Post-Lyme disease syndrome can fulfill fibromyalgia criteria with multiple tender points and widespread pain 1
  • Other central sensitivity syndromes including irritable bowel syndrome, temporomandibular disorder, and interstitial cystitis frequently overlap 6, 5
  • Rheumatologic conditions may coexist with fibromyalgia and require separate evaluation 6

Epidemiologic Context

  • Prevalence is approximately 2% in the general population 1
  • Diagnosed more frequently in women, particularly aged 30-60 years 1, 3
  • Prevalence increases with age 1

References

Guideline

Fibromyalgia Diagnosis and Characteristics

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Fibromyalgia: Diagnosis and Management.

American family physician, 2023

Research

Central sensitivity and fibromyalgia.

Internal medicine journal, 2021

Guideline

Evaluation and Management of Atypical Unilateral Arm Tingling

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.